$NRIX Nurix Therapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nurix Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nurix Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Nurix Therapeutics, Inc. for free.
IRS Number: 270838048
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NRIX
Company Address: 1700 OWENS STREET, SUITE 205 SAN FRANCISCO 94158
Phone number: (415) 660-5320
Former name: Kura Therapeutics, Inc.
Former name: Nurix, Inc., date of change: 2012-05-09
Nurix Therapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 24 2021 | NRIX | Nurix Therapeutics ... | Tong Jeffrey K | Director | Option Exercise | A | 27.38 | 17,500 | 479,150 | 17,500 | |
| May 24 2021 | NRIX | Nurix Therapeutics ... | Chen Leon | Director | Option Exercise | A | 27.38 | 17,500 | 479,150 | 17,500 | |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Ring Christine | General Counsel | Option Exercise | M | 1.86 | 1,200 | 2,232 | 114,466 | |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Ring Christine | General Counsel | Sell | S | 27.00 | 1,200 | 32,400 | 805 | 2 K to 805 (-59.85 %) |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Ring Christine | General Counsel | Buy | M | 1.86 | 1,200 | 2,232 | 2,005 | 805 to 2 K (+149.07 %) |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Beaurang Pierre | Chief Business Offi ... | Option Exercise | M | 1.11 | 7,500 | 8,325 | 29,062 | |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Beaurang Pierre | Chief Business Offi ... | Sell | S | 27.66 | 700 | 19,363 | 4,330 | 5 K to 4.3 K (-13.92 %) |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Beaurang Pierre | Chief Business Offi ... | Sell | S | 26.87 | 2,501 | 67,213 | 5,030 | 7.5 K to 5 K (-33.21 %) |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Beaurang Pierre | Chief Business Offi ... | Sell | S | 26.07 | 4,299 | 112,068 | 7,531 | 11.8 K to 7.5 K (-36.34 %) |
| May 11 2021 | NRIX | Nurix Therapeutics ... | Beaurang Pierre | Chief Business Offi ... | Buy | M | 1.11 | 7,500 | 8,325 | 11,830 | 4.3 K to 11.8 K (+173.21 %) |
| May 10 2021 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Sell | J | 0.00 | 1,085,784 | 0 | 3,422,549 | 4.5 M to 3.4 M (-24.08 %) |
| May 10 2021 | NRIX | Nurix Therapeutics ... | Third Rock Ventures III, L.P. | 10% Owner | Sell | J | 0.00 | 1,085,784 | 0 | 3,422,549 | 4.5 M to 3.4 M (-24.08 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 7,752 | 0 | 48,406 | 40.7 K to 48.4 K (+19.07 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 17,829 | 0 | 139,383 | 121.6 K to 139.4 K (+14.67 %) |
| May 07 2021 | NRIX | Nurix Therapeutics ... | COLUMN GROUP L P | 10% Owner | Buy | J | 0.00 | 17,829 | 0 | 134,010 | 116.2 K to 134 K (+15.35 %) |